Abstract:Abstract Introduction: Gliomas account for majority of primary brain tumors and are composed of different grades, which present distinct molecular alterations, histological characteristics, and response to treatments. Patient-derived xenografts (PDXs) are the most “close-to-patient” models for oncology studies which largely maintain the histo- and molecular- pathology of the original tumors and are widely applied in preclinical evaluations. Subcutaneously inoculated glioma PDX models provide convenient evaluation of treatments’ efficacy but are difficult to mimic the in-situ microenvironment and diffuse invasive growth to peripheral tissue in the brain. Orthotopic implantation of bioluminescent labelled glioma models provides a more relevant preclinical model to evaluate and quantify treatment response. Methods: A glioma PDX model was established by subcutaneously engrafting tumor directly from patient following surgery into immunodeficient mice. Once established and expanded through passaging, glioma cells were isolated from fresh PDX tumor and transduced with pLVX-IRES-ZsGreen1 lentiviral vector, which expressed both luciferase and GFP, rapidly. Cells were then subcutaneously inoculated into immunodeficient mice directly without in vitro culture and selection. Cell sorting of the following tumors based on GFP expression was performed to exclude the luciferase negative cells and enrich for stable luciferase signal in subsequent passages. The in vivo expansion and sorting of GFP+ tumor cells were repeated for two rounds. Cells from third passages of subcutaneous tumor were orthotopically inoculated in the brain of NOD.scid mice. The tumor progression in the brain was further confirmed by the IVIS® Spectrum In Vivo Imaging System. Response of orthotopically inoculated BN2289-Luc to temozolomide was also evaluated according to the bioluminescent signal in brain. Results: We successfully established a luciferase-GFP dual-labeled glioma PDX model BN2289-Luc which was stably passaged in vivo. The successful transduction of luciferase-GFP cascade was detected by in vitro luciferase assay and fluorescence imaging. Stable tumor progression and bioluminescent signal growth of BN2289-Luc were validated orthotopically and subcutaneously in immunodeficient mice, and a histological study revealed the consistency between orthotopic and subcutaneous tumors. Efficacy studies showed that orthotopically inoculated BN2289-Luc responded to temozolomide (25mg/kg, p.o., Day1-5/wkx4wks). Conclusion: An orthotropic glioma PDX model, BN2289-Luc displayed luciferase signal of in situ tumor progression and response to temozolomide treatment, providing an ideal approach for orthotopic investigation of gliomas and preclinical testing of new drugs. Citation Format: Jinxi Wang, Ling Chen, Jun Zhou, Likun Zhang, Jinyu Huang, Xueluan Zhu, Ludovic Bourre, Jingjing Wang. Characterization of orthotopic bioluminescent patient-derived xenograft model of glioma for drug discovery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2387.

Xenotransplantation of Human glioblastoma in Zebrafish larvae: in vivo imaging and proliferation assessment

Abstract 2834: Establishment of orthotopic high grade glioma xenograft model using zebrafish embryos

Clinically Relevant Orthotopic Xenograft Models of Patient-Derived Glioblastoma in Zebrafish

Highlighting the Zebrafish Xenograft Model

The Study of Glioma by Xenotransplantation in Zebrafish Early Life Stages

Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.

Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review

Modelling Glioma Stem Cell-mediated Tumorigenesis Using Zebrafish PDX Systems

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

A Simple, Rapid, and Effective Method for Tumor Xenotransplantation Analysis in Transparent Zebrafish Embryos

Intracranial glioma xenograft model rapidly reestablishes blood-brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents

Abstract 4063: Image-guided fluorescent endomicroscopy of glioblastoma with SVV-GFP viral labeling

Stem-18. A High Throughput Neurosphere Based Colony Formation Assay To Validate Drug And Radiation Effectiveness In Patient Derived Xenolines

Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models

A Novel Xenograft Model In Zebrafish For High-Resolution Investigating Dynamics Of Neovascularization In Tumors

Abstract 2387: Characterization of Orthotopic Bioluminescent Patient-Derived Xenograft Model of Glioma for Drug Discovery

Rabbit Model of Human Gliomas: Implications for Intra-Arterial Drug Delivery

A syngeneic spontaneous zebrafish model of tp53 -deficient, EGFR vIII , and PI3KCA H1047R -driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo

A Synthetic dl-Nordihydroguaiaretic acid (Nordy), Inhibits Angiogenesis, Invasion and Proliferation of Glioma Stem Cells within a Zebrafish Xenotransplantation Model

Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish

Engineering a High-Throughput 3-D in Vitro Glioblastoma Model